/ /

  • linkedin
  • Increase Font
  • Sharebar

    Ocular sealant proves effective for routine, unexpected cases

    Agent migrates to areas that do not have epithelium attached; eye must be dry for adherence


    One sealant (ReSure Sealant, Ocular Therapeutix) is a hydrogel formed in situ. Polyethylene glycol is mixed with trilysine amine to create a polymeric crosslink. It is applied while still in a liquid state and specifically adheres to de-epithelialized tissue on the eye. It then sloughs off as underlying epithelium grows. This material was adapted from neurosurgery applications and has a proven track record for safety and efficacy.

    Gel stent brings new hope for early glaucoma patients

    The sealant is a good preventative measure, as well as a lifesaver, for many unexpected situations, he noted.

    Good flow versus bad flow

    The goal with trabeculectomy (shunt surgery) is to get aqueous to flow out of the eye and into the subconjunctival space, thus lowering pressure.

    However, unexpected leaks exaggerate flow causing serious complications. The goal is to keep IOP in a reasonable range—usually double digits—in the early postoperative period. This way, the eye functions normally, the patient sees well, and postoperative management is straightforward.

    Do we jump on the $70,000 salary bandwagon?

    Unfortunately, even the best glaucoma surgeons get leaks with a certain frequency. Sometimes a patient’s tissue shreds during suturing, making the surgeon alert to issues. Other times, a case seems to have finished very well, but every time the patient blinks there is a miniscule gap between sutures that leaks.

    I have begun applying this sealant as the last step of every filtering procedure. Instead of creating a long-running suture, I most often put in one interrupted suture to secure the conjunctiva back together. I then mix the sealant and apply it to the patient’s eye after the surface is dried. It is ideal for glaucoma surgeries because the sealant automatically migrates to areas that do not have the epithelium attached, even if you cannot visualize the hole.

    Next: Case series

    Robert J. Noecker, MD
    Dr. Noecker, vice chair, University of Pittsburgh Medical Center Eye Center, and director, Glaucoma Service and associate professor of ...

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results